Dr. Feng is a Partner at Sirona Capital, where she leads biotechnology investments with a focus on innovative therapeutics, company creation, and strategic partnerships. Prior to joining Sirona, Dr. Feng held investment roles at leading healthcare venture firms, where she led and executed early- and growth-stage investments, company incubations and cross-border transactions. She also worked at IQVIA, advising global pharmaceutical companies on strategy and operations. Dr. Feng completed her postdoctoral training at Harvard Medical School. She holds a Ph.D. in Immunology from the University of Alabama at Birmingham and a B.S. in Biotechnology from Wuhan University.
